ConductScience.org, home

Paper15040941

Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials.

Fattom AI and 4 others. Vaccine, 2004. Cited by 135 papers, by iCite.

Cite this record

ConductScience Library. Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials. Papers, record 15040941. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15040941

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials.
PubMed
Journal
Vaccine
PubMed
Year
2004
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
135
iCite
Relative citation ratio, by iCite
3.48
iCite
Revised in PubMed
2007-11-15
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fattom AIAli I
2Horwith GGary
3Fuller SSteve
4Propst MMyra
5Naso RRobert

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Staphylococcal InfectionsMajor topic
Staphylococcal VaccinesMajor topic
Animals
Clinical Trials, Phase III as Topic
Humans
Vaccines, Conjugate

Cited by69

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 135 citations.

PMIDTitleJournalYearIn PapersSource
41663438AntiPan: a genome-informed in silico pipeline for advancing subunit vaccine discovery against Staphylococcus aureus.Sci Rep2026https://conductscience.org/library/papers/41663438PubMed
41423820Chemical Synthesis of Pseudomonas aeruginosa, Staphylococcus aureus, and Acinetobacter baumannii Capsular Polysaccharide Fragments as Leads for Cross-Protection.Angew Chem Int Ed Engl2026https://conductscience.org/library/papers/41423820PubMed
40871236Staphylococcus aureus in Foodborne Diseases and Alternative Intervention Strategies to Overcome Antibiotic Resistance by Using Natural Antimicrobials.Microorganisms2025https://conductscience.org/library/papers/40871236PubMed
40823959Synthesis, Conformal Analysis, and Antibody Binding of Staphylococcus aureus Capsular Polysaccharide Type 5 Oligosaccharides.Angew Chem Int Ed Engl2025https://conductscience.org/library/papers/40823959PubMed
39922982Protection of Mice Vaccinated with a New B Cell and T Cell Epitopes Cocktail from Staphylococcus aureus Challenge in Skin Infection Model.Curr Microbiol2025https://conductscience.org/library/papers/39922982PubMed
39792791Long, Synthetic Staphylococcus aureus Type 8 Capsular Oligosaccharides Reveal Structural Epitopes for Effective Immune Recognition.J Am Chem Soc2025https://conductscience.org/library/papers/39792791PubMed
39591106Electron-Beam-Killed Staphylococcus Vaccine Reduced Lameness in Broiler Chickens.Vaccines (Basel)2024https://conductscience.org/library/papers/39591106PubMed
38573919A practical guide for the husbandry of cave and surface invertebrates as the first step in establishing new model organisms.PLoS One2024https://conductscience.org/library/papers/38573919PubMed
38001039Use of Transcriptional Signatures to Differentiate Pathogen-Specific and Treatment-Specific Host Responses in Patients With Bacterial Bloodstream Infections.J Infect Dis2024https://conductscience.org/library/papers/38001039PubMed
37261327Exploring the variables influencing the immune response of traditional and innovative glycoconjugate vaccines.Front Mol Biosci2023https://conductscience.org/library/papers/37261327PubMed
37125490Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STaphylococcus aureus suRgical Inpatient Vaccine Efficacy (STRIVE) Randomized Clinical Trial.Clin Infect Dis2023https://conductscience.org/library/papers/37125490PubMed
36986298Designing a Next-Generation Multiepitope-Based Vaccine against Staphylococcus aureus Using Reverse Vaccinology Approaches.Pathogens2023https://conductscience.org/library/papers/36986298PubMed
35608633Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance.Chem Rev2022https://conductscience.org/library/papers/35608633PubMed
34122448Immunodominance of Epitopes and Protective Efficacy of HI Antigen Are Differentially Altered Using Different Adjuvants in a Mouse Model of Staphylococcus aureus Bacteremia.Front Immunol2021https://conductscience.org/library/papers/34122448PubMed
34088508A protein A based Staphylococcus aureus vaccine with improved safety.Vaccine2021https://conductscience.org/library/papers/34088508PubMed
34069873Staphylococcal Infections: Host and Pathogenic Factors.Microorganisms2021https://conductscience.org/library/papers/34069873PubMed
33562054Immune-Based Anti-Staphylococcal Therapeutic Approaches.Microorganisms2021https://conductscience.org/library/papers/33562054PubMed
33291260T Cell Immunity and the Quest for Protective Vaccines against Staphylococcus aureus Infection.Microorganisms2020https://conductscience.org/library/papers/33291260PubMed
32539814Application of median lethal concentration (LC50) of pathogenic microorganisms and their antigens in vaccine development.BMC Res Notes2020https://conductscience.org/library/papers/32539814PubMed
31133995Absence of Protein A Expression Is Associated With Higher Capsule Production in Staphylococcal Isolates.Front Microbiol2019https://conductscience.org/library/papers/31133995PubMed

See all 69 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/15040941

GET https://conductscience.org/api/papers/v1/15040941/cited_by?page=2